Example searches

ATRI ATRION Corp

Atrion Corp. engages in the manufacture and development of products for medical applications. Its products include cardiac surgery vacuum relief valves, silicone vessel loops, inflation devices, stent deployment, fluid dispensing and products used in heart bypass surgery. The company involves in the fluid delivery as well as ophthalmic and cardiovascular devices. It offers pressure relief valves and inflation systems to the aviation and marine industries. Atrion was founded in 1944 and is headquartered in Allen, TX.

Company profile

Ticker
ATRI
Exchange
NASDAQ
Website
www.atrioncorp.com
CEO
David A. Battat
Employees
Incorporated in
Delaware
Location
Texas
Fiscal year end
Dec 31
Sector
Health Technology > Medical Specialties
Industry (SEC)
Surgical & Medical Instruments & Apparatus
3M • Boston Scientific • Baxter International • Stryker • Becton Dickinson & Co • Teleflex • ResMed • Hill-Rom • Integra Lifesciences • AngioDynamics ...
Former names
Alatenn Resources Inc
SEC CIK
0000701288
Corporate docs
IRS number
630821819

ATRI stock data

(
)

Calendar

26 May 20
5 Jul 20
31 Dec 20

News

Company financial data Financial data

Chart ATRI financial data
Quarter (USD) Mar 20 Dec 19 Sep 19 Jun 19
Revenue 43.59M 34.47M 38.88M 40.1M
Net income 8.9M 8.06M 9.6M 9.66M
Diluted EPS 4.79 4.33 5.15 5.18
Net profit margin 20.41% 23.40% 24.68% 24.10%
Operating income 11.71M 8.08M 10.45M 10.97M
Net change in cash 5.14M -24.73M 14.07M 5.56M
Cash on hand 44.08M 38.94M 63.67M 49.6M
Cost of revenue 23.73M 18.96M 20.99M 21.51M
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue 155.07M 152.45M 146.6M 143.49M
Net income 36.76M 34.26M 36.59M 27.58M
Diluted EPS 19.73 18.44 19.71 14.85
Net profit margin 23.71% 22.47% 24.96% 19.22%
Operating income 40.53M 41.71M 41.27M 39.13M
Net change in cash -2.83M 29.04M 2.01M -5.29M
Cash on hand 38.94M 41.77M 12.73M 10.72M
Cost of revenue 84.38M 80.67M 75.84M 75.86M

Financial data from ATRION earnings reports

Recent insider trades

ATRI insider ownership history Insider history
Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
1 Jul 20 Athey Preston G Common Stock Grant Aquire A No 0 24 0 619
1 Jul 20 Morgan Hugh J JR Common Stock Grant Aquire A No 0 24 0 16,915
1 Jul 20 Spaulding Ronald Nicholas Common Stock Grant Aquire A No 0 24 0 2,245
1 Jul 20 Stupp John P JR Common Stock Grant Aquire A No 0 24 0 5,961
1 Jul 20 Battat David A RSU Common Stock Grant Aquire A No 0 1,545.83 0 1,545.83
Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q1 2020

ATRI institutional ownership history Ownership history
65.5% owned by funds/institutions
13F holders
 Current Prev Q Change
Total holders 137 140 -2.1%
Opened positions 13 21 -38.1%
Closed positions 16 18 -11.1%
Increased positions 38 42 -9.5%
Reduced positions 59 44 +34.1%
13F shares
 Current Prev Q Change
Total value 782.53M 916.08M -14.6%
Total shares 1.2M 1.22M -1.2%
Total puts 0 0
Total calls 0 0
Total put/call ratio – – –
Largest owners
 Shares Value Change
Kayne Anderson Rudnick Investment Management 195.19K $126.87M +5.7%
NEU Neuberger Berman 165.3K $107.45M +1.2%
N Price T Rowe Associates 145.78K $94.76M -0.4%
BLK BlackRock 104.88K $68.17M -1.0%
Vanguard 92.85K $60.35M +0.7%
Dimensional Fund Advisors 62.82K $40.83M -0.3%
Renaissance Technologies 48.7K $31.66M -1.8%
STT State Street 48.22K $31.34M +3.6%
Royce & Associates 33.73K $21.93M -5.3%
Geode Capital Management 23.09K $15.01M +6.0%
Largest transactions
 Shares Bought/sold Change
Kayne Anderson Rudnick Investment Management 195.19K +10.58K +5.7%
Adage Capital Partners GP, L.L.C. 0 -7.5K EXIT
AMP Ameriprise Financial 11.45K -6.88K -37.5%
DF Dent & Co 6.58K +6.58K NEW
First Trust Advisors 0 -5.04K EXIT
IVZ Invesco 5.05K +4.44K +738.0%
Bessemer 7.37K -4.27K -36.7%
Millennium Management 6.24K +3.77K +152.9%
Citadel Advisors 7.17K -3.53K -33.0%
Rhumbline Advisers 10.38K +3.46K +50.0%
Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

?
Management Discussion
  • Our net income was $36.8 million, or $19.82 per basic and $19.73 per diluted share, in 2019 compared to $34.3 million, or $18.49 per basic and $18.44 per diluted share in 2018. Revenues were $155.1 million in 2019 compared with $152.5 million in 2018. 
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: accurately, acquired, advantage, Aid, alternative, asset, aware, Board, bond, cancelled, carrying, CECL, chain, circumstance, classified, clinical, cumulative, curtailed, declared, decline, deemed, default, defer, deferral, demand, disrupt, disruption, diversion, downturn, duration, earlier, economy, efficiency, em, employee, enter, environment, event, evidence, exacerbating, experienced, expiration, extent, footnote, fulfill, fully, GAAP, gathering, global, government, health, healthcare, heightening, impairment, incurred, indefinite, initially, initiated, issuance, key, lead, lifetime, lifted, liquidity, methodology, mitigate, monitor, multiple, nature, negatively, newly, obtained, open, Organization, original, originated, outbreak, pandemic, payroll, portfolio, portion, predict, program, prolonged, prospectively, provision, recommended, recovery, regional, Relief, remote, remotely, respond, Security, short, significantly, spending, spread, supply, sustained, tem, term, terminated, thereof, threat, Topic, training, transparency, unable, uncertainty, Unregistered, voluntary, world, worsening
Removed: Accumulated, applying, assessed, collectability, collection, compensation, Comprehensive, continued, corporate, create, driven, favorable, fourth, greater, improvement, main, mentioned, option, post, posted, presentation, primary, reclassified, reclassifying, reflected, replenishment, site, Subtopic, technology, unrecognized, vast, Web
From filing 10-Q 2020 Q1

Financial reports

View all
10-K/A
2019 FY
Annual report (amended)
26 May 20
10-Q
2020 Q1
Quarterly report
7 May 20
10-K
2019 FY
Annual report
2 Mar 20
10-Q
2019 Q3
Quarterly report
1 Nov 19
10-Q
2019 Q2
Quarterly report
7 Aug 19
10-Q
2019 Q1
Quarterly report
8 May 19
10-K
2018 FY
Annual report
26 Feb 19
10-Q
2018 Q3
Quarterly report
9 Nov 18
10-Q
2018 Q2
Quarterly report
7 Aug 18
10-Q
2018 Q1
Quarterly report
9 May 18

Current reports

View all
8-K
Submission of Matters to a Vote of Security Holders
22 May 20
8-K
Atrion Reports First Quarter Results
7 May 20
8-K
Atrion Reports Results for Fourth Quarter and Full Year 2019
26 Feb 20
8-K
Atrion Reports Third Quarter Results
1 Nov 19
8-K
Atrion Reports Second Quarter Results
7 Aug 19
8-K
Submission of Matters to a Vote of Security Holders
22 May 19
8-K
Atrion Reports First Quarter Results
8 May 19
8-K
Atrion Reports Results for Fourth Quarter and Full Year 2018
26 Feb 19
8-K
Atrion Reports Third Quarter Results
9 Nov 18
8-K
Atrion Reports Second Quarter Results
7 Aug 18

Registration and prospectus

View all
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Aug 18
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Aug 18
S-8
Registration of securities for employees
11 Mar 11
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Dec 10
POS AM
Prospectus update (post-effective amendment)
14 Dec 10
S-8
Registration of securities for employees
27 Jun 07
S-8
Registration of securities for employees
27 Jun 07
S-8
Registration of securities for employees
14 May 07
8-A12B
Registration of securities on exchange
10 Aug 06
SC TO-I/A
Issuer tender offer statement (amended)
21 Apr 03

Proxies

View all
DEFA14A
Additional proxy soliciting materials
6 Apr 20
DEF 14A
Definitive proxy
6 Apr 20
DEFA14A
Additional proxy soliciting materials
8 Apr 19
DEF 14A
Definitive proxy
8 Apr 19
DEF 14A
Definitive proxy
9 Apr 18
DEFA14A
Additional proxy soliciting materials
9 Apr 18
DEF 14A
Definitive proxy
10 Apr 17
DEFA14A
Additional proxy soliciting materials
10 Apr 17
DEF 14A
Definitive proxy
12 Apr 16
DEFA14A
Additional proxy soliciting materials
12 Apr 16

Other

SD
Conflict minerals disclosure
20 May 20
SD
Conflict minerals disclosure
29 May 19
SD
Conflict minerals disclosure
16 May 18
SD
Conflict minerals disclosure
31 May 17
SD
Conflict minerals disclosure
27 May 16
SD
Conflict minerals disclosure
29 May 15
SD
Conflict minerals disclosure
30 May 14

Ownership

View all
4
ATRION / JEFFERY STRICKLAND ownership change
2 Jul 20
4
ATRION / EMILE A BATTAT ownership change
2 Jul 20
4
ATRION / David A Battat ownership change
2 Jul 20
4
ATRION / Ronald Nicholas Spaulding ownership change
2 Jul 20
4
ATRION / JOHN P STUPP JR ownership change
2 Jul 20
4
ATRION / HUGH J MORGAN JR ownership change
2 Jul 20
4
ATRION / Preston G Athey ownership change
2 Jul 20
4
ATRION / Preston G Athey ownership change
22 May 20
4
ATRION / HUGH J MORGAN JR ownership change
22 May 20
4
ATRION / Ronald Nicholas Spaulding ownership change
22 May 20

Patents

GRANT
Utility
Male reflux valve
12 May 20
A male reflux valve comprising a distal body portion and a proximal body portion, the proximal body portion having a male connection for connection to a female connection of an access device, a valve element operatively positioned within the distal body portion, a core operatively positioned within the distal body portion to retain the valve element into sealing engagement with the distal body portion and an actuator reciprocably retained within a generally circular cylindrical longitudinal bore of the proximal body portion in engagement with the valve element to open the valve element when engaged by the female connection of the access device.
GRANT
Utility
Spring-powered, hydraulically-operated intraocular lens inserter
7 Apr 20
An intraocular lens inserter for use during cataract surgery for delivering an intraocular lens (IOL) loaded into an IOL cartridge into a patient's eye.